| 发明名称 |
Otamixaban for Use in the Treatment of Non-ST Elevation Acute Coronary Syndrome in Patients Planned to Undergo Coronary Artery Bypass Grafting |
| 摘要 |
The invention relates to otamixaban or a pharmaceutically acceptable salt thereof for use in the treatment of non-ST elevation acute coronary syndrome in patients planned to undergo coronary artery bypass grafting. |
| 申请公布号 |
US2015202190(A1) |
申请公布日期 |
2015.07.23 |
| 申请号 |
US201314424529 |
申请日期 |
2013.08.29 |
| 申请人 |
SANOFI |
发明人 |
Gaudin Christophe;Moryusef Angèle |
| 分类号 |
A61K31/4418 |
主分类号 |
A61K31/4418 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for treating non-ST elevation acute coronary syndrome in a patient planned to undergo coronary artery bypass grafting, the method comprising administrating to the patient an effective amount of (2R,3R)-2-(3-carbamimidoyl-benzyl)-3-[4-(1-oxy-pyridin-4-yl)benzoylamino]-butyric acid methyl ester or a pharmaceutically acceptable salt thereof. |
| 地址 |
Paris FR |
